Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.

Houdu, Benjamin; Lasnon, Charline; Licaj, Idlir; Thomas, Guy; Do, Pascal; Guizard, Anne-Valerie; Desmonts, Cédric; Aide, Nicolas

Houdu, Benjamin; Lasnon, Charline; Licaj, Idlir; Thomas, Guy; Do, Pascal; Guizard, Anne-Valerie; Desmonts, Cédric; Aide, Nicolas.

Afiliação

Houdu B; Nuclear Medicine Department, University Hospital, Caen, France.
Lasnon C; Nuclear Medicine Department, François Baclesse Cancer Centre, Caen, France.
Licaj I; INSERM ANTICIPE, Normandie University, Caen, France.
Thomas G; Clinical Research Department, François Baclesse Cancer Centre, Caen, France.
Do P; Medical Informatics Department, François Baclesse Cancer Centre, Caen, France.
Guizard AV; Lung Cancer Unit, François Baclesse Cancer Centre, Caen, France.
Desmonts C; Regional Cancer Registry, François Baclesse Cancer Centre, Caen, France.
Aide N; Nuclear Medicine Department, University Hospital, Caen, France.

Eur J Nucl Med Mol Imaging ; 46(2): 533-534, 2019 02.

Article em En | MEDLINE | ID: mdl-30535744

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article